跳至主要内容
临床试验/IRCT20170705034915N2
IRCT20170705034915N2已完成2 期

Investigation of Effectiveness of AllergyCut on Reducing the Severity and intensity of Disease in Allergic Rhinitis Patients

MIM Daroo Pharmaceutical Co.0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients with Rhinitis after diagnosis by an immunologist or ENT physician
  • Male and female patient who has symptoms of allergic rhinitis at least one month per year.
  • A patient aged over 16 years old up to 60 years old who has the opportunity to complete the day care and has an effective relationship with the counselor.
  • A patient who does not have allergy to herbal medicines.

排除标准

  • Patient with rhinitis without diagnosis of immunological basis.
  • Patients who do not want to start or continue treatment are not eligible for study.
  • Patients who provide incomplete data to the counselor.

研究者

发起方
MIM Daroo Pharmaceutical Co.

相似试验